Cargando…

Toxic epidermal necrolysis

Toxic epidermal necrolysis (TEN) is a rare, life-threatening drug-induced skin disease with a mortality rate of approximately 30%. The clinical hallmark of TEN is a marked skin detachment caused by extensive keratinocyte cell death associated with mucosal involvement. The exact pathogenic mechanism...

Descripción completa

Detalles Bibliográficos
Autores principales: Hoetzenecker, Wolfram, Mehra, Tarun, Saulite, Ieva, Glatz, Martin, Schmid-Grendelmeier, Peter, Guenova, Emmanuella, Cozzio, Antonio, French, Lars E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: F1000Research 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4879934/
https://www.ncbi.nlm.nih.gov/pubmed/27239294
http://dx.doi.org/10.12688/f1000research.7574.1
_version_ 1782433746450907136
author Hoetzenecker, Wolfram
Mehra, Tarun
Saulite, Ieva
Glatz, Martin
Schmid-Grendelmeier, Peter
Guenova, Emmanuella
Cozzio, Antonio
French, Lars E.
author_facet Hoetzenecker, Wolfram
Mehra, Tarun
Saulite, Ieva
Glatz, Martin
Schmid-Grendelmeier, Peter
Guenova, Emmanuella
Cozzio, Antonio
French, Lars E.
author_sort Hoetzenecker, Wolfram
collection PubMed
description Toxic epidermal necrolysis (TEN) is a rare, life-threatening drug-induced skin disease with a mortality rate of approximately 30%. The clinical hallmark of TEN is a marked skin detachment caused by extensive keratinocyte cell death associated with mucosal involvement. The exact pathogenic mechanism of TEN is still uncertain. Recent advances in this field have led to the identification of several factors that might contribute to the induction of excessive apoptosis of keratinocytes. In addition, specific human leukocyte antigen types seem to be associated with certain drugs and the development of TEN. As well-controlled studies are lacking, patients are treated with various immunomodulators (e.g. intravenous immunoglobulin) in addition to the best supportive care.
format Online
Article
Text
id pubmed-4879934
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher F1000Research
record_format MEDLINE/PubMed
spelling pubmed-48799342016-05-26 Toxic epidermal necrolysis Hoetzenecker, Wolfram Mehra, Tarun Saulite, Ieva Glatz, Martin Schmid-Grendelmeier, Peter Guenova, Emmanuella Cozzio, Antonio French, Lars E. F1000Res Review Toxic epidermal necrolysis (TEN) is a rare, life-threatening drug-induced skin disease with a mortality rate of approximately 30%. The clinical hallmark of TEN is a marked skin detachment caused by extensive keratinocyte cell death associated with mucosal involvement. The exact pathogenic mechanism of TEN is still uncertain. Recent advances in this field have led to the identification of several factors that might contribute to the induction of excessive apoptosis of keratinocytes. In addition, specific human leukocyte antigen types seem to be associated with certain drugs and the development of TEN. As well-controlled studies are lacking, patients are treated with various immunomodulators (e.g. intravenous immunoglobulin) in addition to the best supportive care. F1000Research 2016-05-20 /pmc/articles/PMC4879934/ /pubmed/27239294 http://dx.doi.org/10.12688/f1000research.7574.1 Text en Copyright: © 2016 Hoetzenecker W et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review
Hoetzenecker, Wolfram
Mehra, Tarun
Saulite, Ieva
Glatz, Martin
Schmid-Grendelmeier, Peter
Guenova, Emmanuella
Cozzio, Antonio
French, Lars E.
Toxic epidermal necrolysis
title Toxic epidermal necrolysis
title_full Toxic epidermal necrolysis
title_fullStr Toxic epidermal necrolysis
title_full_unstemmed Toxic epidermal necrolysis
title_short Toxic epidermal necrolysis
title_sort toxic epidermal necrolysis
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4879934/
https://www.ncbi.nlm.nih.gov/pubmed/27239294
http://dx.doi.org/10.12688/f1000research.7574.1
work_keys_str_mv AT hoetzeneckerwolfram toxicepidermalnecrolysis
AT mehratarun toxicepidermalnecrolysis
AT sauliteieva toxicepidermalnecrolysis
AT glatzmartin toxicepidermalnecrolysis
AT schmidgrendelmeierpeter toxicepidermalnecrolysis
AT guenovaemmanuella toxicepidermalnecrolysis
AT cozzioantonio toxicepidermalnecrolysis
AT frenchlarse toxicepidermalnecrolysis